GLP-1 medications reduced the risk of major adverse cardiovascular events by 13% compared to a placebo, according to a study published Nov. 25 in The Lancet Diabetes & Endocrinology.

In this randomized controlled trial, among patients with a history of myocardial infarction (MI), interruption of long-term beta-blocker therapy was not found to be noninferior to beta-blocker ...

The minister also reviewed the progress of the STEMI Project, which aims to improve emergency cardiac care across the state.

USA: A recent research examining elderly patients (aged >=75) with non-ST-segment-elevation acute coronary syndrome (ACS) ...

Delaying noncardiac surgeries for three to six months following a heart attack appears safer for those who undergo r ...

Can AI predict heart disease better than doctors? The new AIRE model uses ECG data to accurately predict mortality and ...

There was no meaningful protection from major cardiac events after MI, reported investigators of the multinational placebo-controlled trial that is challenging common clinical practice.

non-STEMI; and ACE I, angiotensin-converting enzyme inhibitor. Phentolamine, an α-antagonist used predominantly in the treatment of hypertensive emergencies, appears to benefit cocaine-using patients ...

Cardiac arrest (when the heart stops beating) interrupts circulation, causing brain cells to start dying in less than five minutes of the brain going without needed oxygen in the blood. The ...

First, many cardiac arrhythmias are actually benign and may not produce any symptoms at all. Second, all the symptoms commonly associated with cardiac arrhythmias may be due to non-arrhythmia causes.

Pneumonia, frequently intertwined with cardiovascular disease, escalates the risk of heart complications like heart attacks ...

Invasive Treatment Strategy for Older Patients With Myocardial Infarction. N Engl J Med 2024;391:1673-84. Editorial: Biscaglia S. SENIOR-RITA — Is It All about Angiography? N Engl J Med ...